Nevin Dinççağ

Nevin Dinççağ

Auto-generated profile, based on publicly available information

Nevin Dinççağ

Department of Internal Medicine and Division of Endocrinology and Metabolic Diseases, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
SDSelcuk Dagdelen
Selcuk Dagdelen
ODOguzhan Deyneli
Oguzhan Deyneli
NDNevin Dinccag
Nevin Dinccag
HIHasan Ilkova
Hasan Ilkova
ZSZeynep Osar Siva
Zeynep Osar Siva
TYTemel Yilmaz
Temel Yilmaz
This expert panel of diabetes specialists aimed to provide guidance to healthcare providers on the best practice in the use of innovative continuous glucose monitoring (CGM) techniques through a practical and implementable document that specifically addresses the rationale for and also analysis and interpretation of the new standardized glucose reporting system based on standardized CGM metrics and visual ambulatory glucose profile (AGP) data. This guidance document presents recommendations and a useful algorithm for the use of a standardized glucose reporting system in the routine diabetes care setting.

25 April 2022 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
BCBulent Can
Bulent Can
YTYILDIZ TUTUNCU
YILDIZ TUTUNCU
BCBusra Can
Busra Can
HKHavva Keskin
Havva Keskin
SBSeldag Bekpinar
Seldag Bekpinar
NDNevin Dinccag
Nevin Dinccag
The progression of gestational diabetes mellitus (GDM) to metabolic syndrome (MetS) is associated with systemic inflammation. The aim of this study was to compare the levels of inflammatory markers in former GDM patients with and without MetS. Medical records were screened retrospectively for patients who were diagnosed with GDM 10 (±2) years ago. Former GDM patients were invited to the hospital for an assessment of their current health status. Of 52 women with former GDM, 27 (52%) had MetS. C-reactive protein (CRP), interleukin-6 and plasminogen activator inhibitor-1 (PAI-1) levels were significantly higher in the MetS group while adiponectin was significantly lower (p < .001, p = .037, p = .002 and p = .013, respectively). There was no significant difference in plasma levels of visfatin and tumour necrosis factor-α. Interleukin-6, CRP, PAI-1 and adiponectin may be used as biomarkers to detect MetS in the pre-clinical phase. With timely diagnosis, early interventions can be implemented.

31 August 2018 in Journal of Nutrition and Dietetics
Verified
Journal Article
Closed access
PDF file
SÇSelda Çelik
Selda Çelik
IIIdiz Idiz
Idiz Idiz
EBElif Bağdemir
Elif Bağdemir
SPSevim Purisa
Sevim Purisa
NDNevin Dinççağ
Nevin Dinççağ
ISIlhan Satman
Ilhan Satman
Amaç: Bu çalışma diabetes mellitus nedeniyle izlenen hastalarda kan şekeri ölçüm sıklığı ile diyabet regülasyonu ve diyabetin komplikasyonları arasındaki ilişkiyi belirlemek amacıyla yapılmıştır. Bireyler ve Yöntem: Çalışma 951 diyabetli hastanın (tip1= 90, tip2= 861) dosyalarının retrospektif olarak incelenmesi ile gerçekleştirilmiştir. Hastaların yaşı, cinsiyeti, boyu, ağırlığı, diyabet tipi, diyabet süresi, diyabet tedavisi, hemoglobin A1c (HbA1c) değeri, nöropati varlığı, nefropati varlığı, diyabetik ayak varlığı, hipertansiyon varlığı, kan şekeri ölçüm sıklığı bilgileri not edilmiştir. Kan şekeri ölçüm sıklıklarına göre hastalar 3 gruba ayrılmıştır: haftada en az iki gün toplam 8 kez kan şekeri ölçümü yapanlar (grup 1), haftada iki günden az ve 8 ölçümden az kan şekeri ölçümü yapanlar (grup 2), düzensiz kan şekeri ölçümü yapmalarına rağmen doktor kontrolüne gelmeden önceki 2 gün içerisinde 8 kez kan şekeri ölçümü yapanlar (grup 3). Bulgular: Hastaların 548’i kadın, 403’ü erkek, ortalama yaş 58.12±13.17 yıldır. Gruplar arasında HbA1c (p<0.001) ve diyabet süresi (p<0.001) parametrelerinde anlamlı fark belirlenmiştir. Hastaların kan şekeri ölçüm sıklığı ile diyabet tipi (p<0.001), diyabet tedavi şekli (p<0.001), retinopati varlığı (p<0.001), nefropati varlığı (p<0.001), hipertansiyon varlığı (p<0.001) arasında anlamlı bir fark olduğu saptanmıştır. Sonuç: Doğru ölçüm tekniği ve güvenilir kan şekeri ölçüm aletleri ile yapılan kan şekeri ölçümü, hastanın diyabeti tanıması ve yönetmesine imkân tanımakla birlikte diyabete bağlı gelişebilecek komplikasyonların önüne geçilmesinde yardımcı olmaktadır.

1 January 2025 in Journal of Diabetes Research
Verified
Journal Article
Open access
RÇRamazan Çakmak
Ramazan Çakmak
OCOzge Telci Caklili
Ozge Telci Caklili
AKAyşe Merve Ok Kurt
Ayşe Merve Ok Kurt
ÜMÜmmü Mutlu
Ümmü Mutlu
GSGöktuğ Sarıbeyliler
Göktuğ Sarıbeyliler
ISIlhan Satman
Ilhan Satman
Background and Aims: The age‐at‐onset is of great importance in the heterogeneity of Type 1 diabetes mellitus (T1DM). This study was designed to define clinical and laboratory differences between child–adolescent‐onset and adult‐onset T1DM at presentation and during follow‐up and determine the predicting factors for developing microvascular and macrovascular complications. Material and Methods: This retrospective observational study evaluated T1DM patients who were followed in the diabetes outpatient clinic between January 1, 2000, and December 31, 2019. Results: The study cohort included 490 individuals with T1DM (54.3% female, 58.8% adult‐onset, and median follow‐up: 5 years). In the adult‐onset group, baseline C‐peptide and GADA prevalence were higher, whereas presentation with ketoacidosis was 2.3‐fold lower compared to the child–adolescent‐onset group ( p < 0.001). During follow‐up, the adult‐onset group had a 2.4‐fold higher overweight/obesity ( p < 0.001) and 1.7‐fold higher dyslipidemia/hyperlipidemia ( p = 0.002) than the child–adolescent‐onset group. In multivariate analysis, fasting glucose ( p = 0.024) in adult‐onset, dyslipidemia/hyperlipidemia ( p = 0.037) in child–adolescent‐onset, and diabetes duration ( p = 0.008 and p = 0.007) and hypertension ( p = 0.001 and p = 0.01) in both groups were associated with increased risk of microvascular complications, whereas age‐at‐onset ( p = 0.024), dyslipidemia/hyperlipidemia ( p = 0.03), nephropathy ( p = 0.003), and neuropathy ( p = 0.001) in adult‐onset and age ( p = 0.002) and triglycerides ( p = 0.013) in child–adolescent‐onset groups were associated with increased risk of macrovascular complications. The cutoff C‐peptide levels at baseline predicted microvascular complications in the whole cohort and adult‐onset group were defined as 0.383 ng/mL ( p < 0.001) and 0.41 ng/mL ( p = 0.001), respectively. In the Kaplan–Meier analysis, C‐peptide (< 0.383 ng/mL) but not age‐at‐onset predicted future development of microvascular and macrovascular complications ( p = 0.003 and p = 0.032). Conclusion: Clinical presentation and prognosis differ in adult‐onset and child–adolescent‐onset T1DM. Low initial C‐peptide may predict the development of microvascular and macrovascular complications.

1 March 2024 in Medical Journal of Bakırkoy
Verified
Journal Article
Closed access
BCBedia Fulya Calikoglu
Bedia Fulya Calikoglu
DGDamla Guzey
Damla Guzey
HHHulya Hacisahinogullari
Hulya Hacisahinogullari
RÇRamazan Çakmak
Ramazan Çakmak
AUAyşe Kubat Uzum
Ayşe Kubat Uzum
ISIlhan Satman
Ilhan Satman